Medivir to present at the H.C. Wainwright 24th Annual Global Investment Conference
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that the company will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022. The presentation is now available on Medivirs website; www.medivir.com. For additional information, please contact Magnus Christensen, CFO, Medivir AB Telephone: +46 8 5468 3100 E-mail: magnus.christensen@medivir.com